- Insiders, including top executives, sold $1.65 million in Zai Lab shares, yet the stock price surged by 56.87% over the past year.
- Analysts maintain a "Strong Buy" rating for ZLAB, with an average price target suggesting an 88.28% upside.
- Based on GuruFocus estimates, ZLAB's GF Value suggests a potential 136.65% gain from the current price.
Zai Lab Limited (NASDAQ: ZLAB), a frontrunner in the biopharmaceutical industry with a focus on oncology and infectious diseases, made headlines recently as key insiders, including the CEO and CFO, divested $1.65 million worth of shares. Despite this insider selling, the stock has impressively rallied, gaining 56.87% over the past year. Bolstering investor confidence, analysts continue to endorse ZLAB with a "Strong Buy" rating, signaling considerable potential for further growth.
Wall Street Analysts' Projections
Investor sentiment remains optimistic as reflected in the one-year price targets shared by 11 analysts. Currently, the average target price for Zai Lab Ltd (ZLAB, Financial) stands at $54.51, with a high estimate of $74.00 and a low estimate of $36.10. This average target price signifies a potential upside of 88.28% from the current price of $28.95. Additional detailed estimates are available on the Zai Lab Ltd (ZLAB) Forecast page.
Reinforcing this optimism, the stock’s "Outperform" status is reflected in the consensus recommendation from 12 brokerage firms, with an average brokerage recommendation of 1.8 on a scale where 1 indicates "Strong Buy" and 5 signifies "Sell".
GuruFocus GF Value Estimation
According to GuruFocus' proprietary metrics, the estimated GF Value for Zai Lab Ltd (ZLAB, Financial) in the coming year is $68.51, suggesting a substantial potential gain of 136.65% from its current price of $28.95. This GF Value is calculated to reflect what the stock should ideally trade at, based on its historical trading multiples, previous business growth, and future business performance forecasts. More insights can be explored on the Zai Lab Ltd (ZLAB) Summary page.
- CEO Buys, CFO Buys: Stocks that are bought by their CEO/CFOs.
- Insider Cluster Buys: Stocks that multiple company officers and directors have bought.
- Double Buys: Companies that both Gurus and Insiders are buying
- Triple Buys: Companies that both Gurus and Insiders are buying, and Company is buying back.
